Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
An allergy is a hypersensitivity disorder of the immune system. The term allergy is used to describe an overreaction to substances in the environment that are harmless for most people, but induce an immune response that causes a variety of symptoms in predisposed people. The immune system is extremely complex and so there are many opportunities for things to go wrong. When the immune system begins to react against harmless substances in the environment, this can lead to allergic reactions. Furthermore, there are three major classes of allergens, Inhaled allergens, food allergens and drug allergens. All these types may cause symptoms like wheezing, coughing, shortness of breath, sneezing, runny nose, itchy, swollen, bumpy, and scaly skin. Moreover, 50 million Americans have allergies and 22 percent of the population is affected throughout the rest of the world. While many patients have allergy symptoms, only a small number are tested to see what causes them. In just 14 years, cases of asthma have increased 160% in U.S. children aged between 0 to 4 years. In addition, the prevalence of clinical food allergies in young children was as high as 10% in developed countries and may affect up to 15-20% of infants. Also, Allergic rhinitis affects 5% to 20% of the population worldwide and with increasing prevalence. Additionally, it needs to be diagnosed and treated properly. Therefore, the diagnostics tests such as skin tests and blood tests are in great demand.
The allergy diagnostics market market has gained remarkable growth owing to increasing environmental pollution, rising healthcare expenditure, disorders due to lifestyle changes. Technological advancements in testing equipment is another factor augmenting the demand of allergy diagnostics market globally. In future, the market growth is predicted to boost due to rising in the testing laboratories and rapid urbanization in developing countries. However, low awareness of allergic diseases and strict government policies & regulations are some restraints which can hamper the growth of the market.
The allergy diagnostics market is segmented by product, allergen, test, end-user and geography.
The segmentation on the basis of product form includes assay kits, instruments and consumables. Whereas, instruments segment is further divided into immunoassay analyzers, luminometers and ELISA analyzers. Among these, Assay kits segment dominated the allergy diagnostics market in 2018. Excessive level of precision, effective performance and reliability are key drivers increasing the demand for assay kits globally.
Based on allergen, the allergy diagnostics market is segmented into inhaled allergens, food allergens and drug allergens. The Inhaled allergens accounted for the largest share in 2018. Owing to, the growing incidences of respiratory allergies. In addition, respiratory allergies are the most common allergies in worldwide. Whereas, in just 14 years, cases of asthma have increased 160 % in U.S. children aged between 0 to 4 years.
The various test types of the allergy diagnostics market are covered in the report such as in-vivo tests and in-vitro tests. Among which, the in vitro test segment dominated the market in 2018. Due to the increasing demand for minimally invasive and allergen specific tests.
On the basis of end-user, the allergy diagnostics market is segmented into diagnostic laboratories, hospitals and academic research institutes. Owing to the largest consumer of allergy diagnostic products hospitals segment dominated the market in 2018.
By geography, the allergy diagnostics market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and Rest of the World. Among these, North America dominated the market in 2018 owing to the rise in number of people with allergies, improved government support, enhanced medical insurance policies. Whereas, Asia Pacific is expected to witness the fastest growth rate during the forecast period due to increasing disposable income, and aging population in the region.
Some key players of this market includes Thermo fisher scientific, Omega diagnostics, Siemens healthcare, Stallergenes greer, Lincoln diagnostics, Biomerieux, Hob biotech group, Alcon laboratories, Hycor biomedical and Hitachi chemical diagnostics. Among others are EUROIMMUN AG, INDOOR Biotechnologies, Inc., R-Biopharm AG, GA Generic Assays GmbH, Tecan Trading AG, ROXALL Medical GmbH, ALK-Abelló A/S, Angsana Molecular & Diagnostics Laboratory Pte Ltd., Allergy Therapeutics and HAL Allergy Group. The major players have used various strategies such as new product launches, market initiatives, high expense on research and development, agreements, partnerships, acquisitions, and others to increase their footprints in this market.
The allergy diagnostics market is segmented by Product, Allergen, Test, End-User and Geography. The segmentation on the basis of product form includes assay kits, instruments and consumables. Whereas, instruments segment is further divided into immunoassay analyzers, luminometers and ELISA analyzers. Among these, Assay kits segment dominated the allergy diagnostics market in 2018.
Based on allergen, the allergy diagnostics market is segmented into inhaled allergens, food allergens and drug allergens. The Inhaled allergens accounted for the largest share in 2018. Owing to, the growing incidences of respiratory allergies.
The various test types of the allergy diagnostics market are covered in the report such as in-vivo tests and in-vitro tests. Among which, the in vitro test segment dominated the market in 2018. Due to the increasing demand for minimally invasive and allergen specific tests.
On the basis of end-user, the allergy diagnostics market is segmented into diagnostic laboratories, hospitals and academic research institutes. Owing to the largest consumer of allergy diagnostic products hospitals segment dominated the market in 2018.
By geography, the allergy diagnostics market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and Rest of the World. Among these, North America dominated the market in 2018 owing to the rise in number of people with allergies, improved government support, enhanced medical insurance policies.
Why to buy this report:
